Table 2 Symptoms in patients on somatostatin analogue treatment for metastatic disease from small-intestinal neuroendocrine tumour EORTC QLQ-C30 values expressed as mean (standard deviation). A higher score (1–100) on functional scales represents a higher level of function, while a higher score (1–100) on symptom scales represents a higher level of symptoms

From: Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours